Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jun;93(6):2332–2339. doi: 10.1172/JCI117238

Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.

J M Alexander 1, A Klibanski 1
PMCID: PMC294438  PMID: 8200967

Abstract

An important question in the pathogenesis and regulation of human gonadotroph adenomas is whether heterogeneous gonadotropin responses to gonadotropin-releasing hormone (GnRH) are due to dysregulation of GnRH receptor biosynthesis and/or cell-signaling pathways. We investigated gonadotropin responsiveness to pulsatile GnRH in 13 gonadotroph adenomas. All tumors had evidence of follicle-stimulating hormone (FSH) beta and alpha subunit biosynthesis using reverse transcriptase/polymerase chain reaction (RTPCR) techniques. Four tumors significantly increased gonadotropin and/or free subunit secretion during pulsatile 10(-8) M GnRH administration. The GnRH antagonist Antide (10(-6) to 10(-8) M) blocked secretory increases in all GnRH-responsive tumors. Gonadotropin and/or free subunit secretion increased after 60 mM KCl, confirming that GnRH nonresponsiveness was not due to intracellular gonadotropin depletion. We hypothesized that GnRH nonresponsiveness in these tumors may be due to GnRH receptor (GnRH-Rc) biosynthetic defects. RTPCR analyses detected GnRH-Rc transcripts only in responsive tumors and normal human pituitary. This is the first demonstration of a cell-surface receptor biosynthetic defect in human pituitary tumors. We conclude (a) one third of gonadotroph tumors respond to pulsatile GnRH in vitro, (b) GnRH-Rc mRNA is detected in human gonadotroph adenomas and predicts GnRH responsiveness, and (c) GnRH-Rc biosynthetic defects may underlie GnRH nonresponsiveness in gonadotroph tumors.

Full text

PDF
2332

Images in this article

2335Image
on p.2335
2335Image
on p.2335
2335Image
on p.2335
2336Image
on p.2336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. M., Biller B. M., Bikkal H., Zervas N. T., Arnold A., Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 1990 Jul;86(1):336–340. doi: 10.1172/JCI114705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexander M., Curtis G., Avruch J., Goodman H. M. Insulin regulation of protein biosynthesis in differentiated 3T3 adipocytes. Regulation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1985 Oct 5;260(22):11978–11985. [PubMed] [Google Scholar]
  3. Biller B. M., Alexander J. M., Zervas N. T., Hedley-Whyte E. T., Arnold A., Klibanski A. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab. 1992 Nov;75(5):1303–1309. doi: 10.1210/jcem.75.5.1358909. [DOI] [PubMed] [Google Scholar]
  4. Black P. M., Hsu D. W., Klibanski A., Kliman B., Jameson J. L., Ridgway E. C., Hedley-Whyte E. T., Zervas N. T. Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg. 1987 Feb;66(2):244–250. doi: 10.3171/jns.1987.66.2.0244. [DOI] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Danforth D. R., Williams R. F., Gordon K., Hodgen G. D. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action. Endocrinology. 1991 Apr;128(4):2036–2040. doi: 10.1210/endo-128-4-2036. [DOI] [PubMed] [Google Scholar]
  7. Edmonds M., Molitch M., Pierce J. G., Odell W. D. Secretion of alpha subunits of luteinizing hormone (LH) by the anterior pituitary. J Clin Endocrinol Metab. 1975 Sep;41(3):551–555. doi: 10.1210/jcem-41-3-551. [DOI] [PubMed] [Google Scholar]
  8. Gaylinn B. D., Harrison J. K., Zysk J. R., Lyons C. E., Lynch K. R., Thorner M. O. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol. 1993 Jan;7(1):77–84. doi: 10.1210/mend.7.1.7680413. [DOI] [PubMed] [Google Scholar]
  9. Gicquel C., Le Bouc Y., Luton J. P., Girard F., Bertagna X. Monoclonality of corticotroph macroadenomas in Cushing's disease. J Clin Endocrinol Metab. 1992 Aug;75(2):472–475. doi: 10.1210/jcem.75.2.1322426. [DOI] [PubMed] [Google Scholar]
  10. Haisenleder D. J., Ortolano G. A., Yasin M., Dalkin A. C., Marshall J. C. Regulation of gonadotropin subunit messenger ribonucleic acid expression by gonadotropin-releasing hormone pulse amplitude in vitro. Endocrinology. 1993 Mar;132(3):1292–1296. doi: 10.1210/endo.132.3.7679975. [DOI] [PubMed] [Google Scholar]
  11. Herman V., Fagin J., Gonsky R., Kovacs K., Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990 Dec;71(6):1427–1433. doi: 10.1210/jcem-71-6-1427. [DOI] [PubMed] [Google Scholar]
  12. Hsieh K. P., Martin T. F. Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Mol Endocrinol. 1992 Oct;6(10):1673–1681. doi: 10.1210/mend.6.10.1333052. [DOI] [PubMed] [Google Scholar]
  13. Hsu D. W., Riskind P. N., Hedley-Whyte E. T. Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study. Am J Pathol. 1989 Aug;135(2):329–338. [PMC free article] [PubMed] [Google Scholar]
  14. Jacoby L. B., Hedley-Whyte E. T., Pulaski K., Seizinger B. R., Martuza R. L. Clonal origin of pituitary adenomas. J Neurosurg. 1990 Nov;73(5):731–735. doi: 10.3171/jns.1990.73.5.0731. [DOI] [PubMed] [Google Scholar]
  15. Jameson J. L., Klibanski A., Black P. M., Zervas N. T., Lindell C. M., Hsu D. W., Ridgway E. C., Habener J. F. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest. 1987 Nov;80(5):1472–1478. doi: 10.1172/JCI113228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaiser U. B., Jakubowiak A., Steinberger A., Chin W. W. Regulation of rat pituitary gonadotropin-releasing hormone receptor mRNA levels in vivo and in vitro. Endocrinology. 1993 Aug;133(2):931–934. doi: 10.1210/endo.133.2.8393779. [DOI] [PubMed] [Google Scholar]
  17. Kalinec G., Nazarali A. J., Hermouet S., Xu N., Gutkind J. S. Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. Mol Cell Biol. 1992 Oct;12(10):4687–4693. doi: 10.1128/mcb.12.10.4687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Katznelson L., Alexander J. M., Bikkal H. A., Jameson J. L., Hsu D. W., Klibanski A. Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas. J Clin Endocrinol Metab. 1992 Jun;74(6):1343–1351. doi: 10.1210/jcem.74.6.1375599. [DOI] [PubMed] [Google Scholar]
  19. Katznelson L., Alexander J. M., Klibanski A. Clinical review 45: Clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 1993 May;76(5):1089–1094. doi: 10.1210/jcem.76.5.8496297. [DOI] [PubMed] [Google Scholar]
  20. Klibanski A., Deutsch P. J., Jameson J. L., Ridgway E. C., Crowley W. F., Hsu D. W., Habener J. F., Black P. M. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. J Clin Endocrinol Metab. 1987 Mar;64(3):536–542. doi: 10.1210/jcem-64-3-536. [DOI] [PubMed] [Google Scholar]
  21. Klibanski A., Jameson J. L., Biller B. M., Crowley W. F., Jr, Zervas N. T., Rivier J., Vale W. W., Bikkal H. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. J Clin Endocrinol Metab. 1989 Jan;68(1):81–86. doi: 10.1210/jcem-68-1-81. [DOI] [PubMed] [Google Scholar]
  22. Klibanski A., Shupnik M. A., Bikkal H. A., Black P. M., Kliman B., Zervas N. T. Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors. J Clin Endocrinol Metab. 1988 Jan;66(1):96–102. doi: 10.1210/jcem-66-1-96. [DOI] [PubMed] [Google Scholar]
  23. Kourides I. A., Weintraub B. D., Levko M. A., Maloof F. Alpha and beta subunits of human thyrotropin: purification and development of specific radioimmunoassays. Endocrinology. 1974 May;94(5):1411–1421. doi: 10.1210/endo-94-5-1411. [DOI] [PubMed] [Google Scholar]
  24. Kwekkeboom D. J., de Jong F. H., Lamberts S. W. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J Clin Endocrinol Metab. 1989 Jun;68(6):1128–1135. doi: 10.1210/jcem-68-6-1128. [DOI] [PubMed] [Google Scholar]
  25. Lamberts S. W., Verleun T., Oosterom R., Hofland L., van Ginkel L. A., Loeber J. G., van Vroonhoven C. C., Stefanko S. Z., de Jong F. H. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab. 1987 Mar;64(3):524–530. doi: 10.1210/jcem-64-3-524. [DOI] [PubMed] [Google Scholar]
  26. Mansfield M. J., Beardsworth D. E., Loughlin J. S., Crawford J. D., Bode H. H., Rivier J., Vale W., Kushner D. C., Crigler J. F., Jr, Crowley W. F., Jr Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. N Engl J Med. 1983 Nov 24;309(21):1286–1290. doi: 10.1056/NEJM198311243092104. [DOI] [PubMed] [Google Scholar]
  27. Mayo K. E. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol Endocrinol. 1992 Oct;6(10):1734–1744. doi: 10.1210/mend.6.10.1333056. [DOI] [PubMed] [Google Scholar]
  28. McGrath G. A., Goncalves R. J., Udupa J. K., Grossman R. I., Pavlou S. N., Molitch M. E., Rivier J., Vale W. W., Snyder P. J. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist. J Clin Endocrinol Metab. 1993 May;76(5):1363–1368. doi: 10.1210/jcem.76.5.8496331. [DOI] [PubMed] [Google Scholar]
  29. Schulte H. M., Oldfield E. H., Allolio B., Katz D. A., Berkman R. A., Ali I. U. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab. 1991 Dec;73(6):1302–1308. doi: 10.1210/jcem-73-6-1302. [DOI] [PubMed] [Google Scholar]
  30. Shupnik M. A. Effects of gonadotropin-releasing hormone on rat gonadotropin gene transcription in vitro: requirement for pulsatile administration for luteinizing hormone-beta gene stimulation. Mol Endocrinol. 1990 Oct;4(10):1444–1450. doi: 10.1210/mend-4-10-1444. [DOI] [PubMed] [Google Scholar]
  31. Simon M. I., Strathmann M. P., Gautam N. Diversity of G proteins in signal transduction. Science. 1991 May 10;252(5007):802–808. doi: 10.1126/science.1902986. [DOI] [PubMed] [Google Scholar]
  32. Snyder P. J., Bashey H. M., Kim S. U., Chappel S. C. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. J Clin Endocrinol Metab. 1984 Dec;59(6):1169–1175. doi: 10.1210/jcem-59-6-1169. [DOI] [PubMed] [Google Scholar]
  33. Snyder P. J., Johnson J., Muzyka R. Abnormal secretion of glycoprotein alpha-subunit and follicle-stimulating hormone (FSH) beta-subunit in men with pituitary adenomas and FSH hypersecretion. J Clin Endocrinol Metab. 1980 Sep;51(3):579–584. doi: 10.1210/jcem-51-3-579. [DOI] [PubMed] [Google Scholar]
  34. Spada A., Arosio M., Bassetti M., Vallar L., Clementi E., Bazzoni N. Mutations in the alpha subunit of the stimulatory regulatory protein of adenylyl cyclase (Gs) in human GH-secreting pituitary adenomas. Biochemical, clinical, and morphological aspects. Pathol Res Pract. 1991 Jun;187(5):567–570. doi: 10.1016/S0344-0338(11)80145-7. [DOI] [PubMed] [Google Scholar]
  35. Spada A., Reza-Elahi F., Lania A., Gil-del-Alamo P., Bassetti M., Faglia G. Hypothalamic peptides modulate cytosolic free Ca2+ levels and adenylyl cyclase activity in human nonfunctioning pituitary adenomas. J Clin Endocrinol Metab. 1991 Oct;73(4):913–918. doi: 10.1210/jcem-73-4-913. [DOI] [PubMed] [Google Scholar]
  36. Thotakura N. R., Bahl O. P. Highly specific and sensitive hybridoma antibodies against the alpha-subunit of human glycoprotein hormones. Endocrinology. 1985 Oct;117(4):1300–1308. doi: 10.1210/endo-117-4-1300. [DOI] [PubMed] [Google Scholar]
  37. Weiss J., Duca K. A., Crowley W. F., Jr Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells. Endocrinology. 1990 Nov;127(5):2364–2371. doi: 10.1210/endo-127-5-2364. [DOI] [PubMed] [Google Scholar]
  38. Weiss J., Harris P. E., Halvorson L. M., Crowley W. F., Jr, Jameson J. L. Dynamic regulation of follicle-stimulating hormone-beta messenger ribonucleic acid levels by activin and gonadotropin-releasing hormone in perifused rat pituitary cells. Endocrinology. 1992 Sep;131(3):1403–1408. doi: 10.1210/endo.131.3.1505470. [DOI] [PubMed] [Google Scholar]
  39. Weiss J., Jameson J. L., Burrin J. M., Crowley W. F., Jr Divergent responses of gonadotropin subunit messenger RNAs to continuous versus pulsatile gonadotropin-releasing hormone in vitro. Mol Endocrinol. 1990 Apr;4(4):557–564. doi: 10.1210/mend-4-4-557. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES